Jaume Puig Ribera

Prisma Global Asset Management SGIIC SA (Prisma Global) is an asset management firm headquartered in Barcelona, Spain. The firm was founded in 1985 as Merchbanc SGIIC SA and is a subsidiary of Prisma Asset Management SL. Prisma Global manages mutual and pension funds in Luxembourg and Spain.

Grupo Catalana Occidente Gestión de Activos SA SGIIC (GCO Gestión de Activos) is the asset management subsidiary of Grupo Catalana Occidente SA (BME: GCO), ultimately owned by CO Sociedad de Gestión y Participación SA in Spain. The firm was founded in 1976 under the name Seguros Bilbao Fondos SGIIC SA. Headquartered in Barcelona, GCO Gestión de Activos manages investment funds for private and small business clients.

Credit Suisse Gestion SGIIC SA (CSG) is the Spanish bank management subsidiary of Credit Suisse AG (Spain), ultimately owned by Credit Suisse Group (SW: CSGN; ADR: CS) in Switzerland. Founded in 1996, CSG is headquartered in Madrid and manages a range of investment funds and SICAVs for individual and institutional clients.

Vall Companys SA engages in the production and supply of meat and poultry products. It offers beef, pork, lamb, and chicken in fresh, frozen, pre-cooked, and pre-seasoned formats. The company was founded in 1956 and is headquartered in Lleida, Spain.

Alía Gestión Integral de Servicios SL provides civil engineering services. Its services include consultancy, information system, outsourcing, project management, design, and development services. The company was founded in 1966 and is headquartered in Sevilla, Spain.

GVC Gaesco Valores SV SA (Investment Management) (GVC Gaesco-IM) is the wealth management division of GVC Gaesco Valores SV SA, which is owned by GV Gaesco Holding SL in Spain. The firm was founded in 1999 and formerly known as GVC Gaesco Beka SV SA. Headquartered in Barcelona, GVC Gaesco-IM manages and administers assets of individuals, families and businesses.

SOM Innovation Biotech SA engages in the discovery and development of new indications for known drugs. Its pipeline consists of repositioned compounds for the treatment of amyloidosis, huntington's disease, hyperplasia, glioblastoma, and alzheimer's disease. The company was founded by Raul Insa Boronat and Ignasi Belda Reig on December 30, 2009 and is headquartered in Barcelona, Spain.